A NIAID-led clinical trial is set to start to test the safety and efficacy of ZMapp as treatment for Ebola, involving participants from the United States and Liberia.
U.S., Liberia Start Clinical Trial of Expiermental Drug ZMapp For Ebola
Tech Times - 28 Feb 2015 17:29
A NIAID-led clinical trial is set to start to test the safety and efficacy of ZMapp as treatment for Ebola, involving participants from the United States and Liberia.
Share this Article
Recommended